GeneDx Holdings Corp. (WGS): Cash & Equivalents
$105.00M
As of 2025-12-31
$60.32M
As of 2026-06-30
-5.4%
3-year compound annual growth
-0.6%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $105.00M | +23.2% | 2026-02-23, Balance as of period end |
| 2024-12-31 | $85.21M | -14.5% | 2026-02-23, Balance as of period end |
| 2023-12-31 | $99.68M | -19.6% | 2025-02-20, Balance as of period end |
| 2022-12-31 | $123.93M | -69.1% | 2024-02-23, Balance as of period end |
| 2021-12-31 | $400.57M | n/a | 2023-03-16, Balance as of period end |
| 2021-09-30 | $461.28M | n/a | 2022-03-14, Balance as of period end |
| 2021-06-30 | $26.50M | n/a | 2022-03-14, Balance as of period end |
| 2021-03-31 | $58.65M | n/a | 2022-03-14, Balance as of period end |
| 2020-12-31 | $108.13M | n/a | 2023-03-16, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | 2025-12-31 | $105.00M | +23.2% |
| DocGo Inc. (DCGO) | 2025-12-31 | $51.02M | -42.8% |
| Omada Health, Inc. (OMDA) | 2025-12-31 | $222.04M | +190.7% |
| U S Physical Therapy Inc (USPH) | 2025-12-31 | $35.57M | -14.0% |
| Strata Critical Medical, Inc. (SRTA) | 2025-12-31 | $30.97M | +68.5% |
| InnovAge Holding Corp. (INNV) | 2026-06-30 | $97.89M | +52.6% |
| LifeStance Health Group, Inc. (LFST) | 2025-12-31 | $248.64M | +60.9% |
| P3 Health Partners Inc. (PIII) | 2025-12-31 | $25.01M | -35.6% |
| Privia Health Group, Inc. (PRVA) | 2025-12-31 | $479.69M | -2.3% |
Compare WGS, DCGO, OMDA, USPH side by side · Screen every company in Services-Health Services ↗